PMID- 24529185 OWN - NLM STAT- MEDLINE DCOM- 20150928 LR - 20151119 IS - 1478-3231 (Electronic) IS - 1478-3223 (Linking) VI - 35 IP - 1 DP - 2015 Jan TI - Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human. PG - 198-206 LID - 10.1111/liv.12504 [doi] AB - BACKGROUND & AIMS: Homozygous individuals with alpha-1-antitrypsin deficiency (AATD) type PiZ have an increased risk of chronic liver disease and hepatocellular carcinoma (HCC). It is noteworthy that HCCs are composed by hepatocytes without accumulation of AAT, but the reason for this remains unclear. The aim of this study was to determine liver pathology in PiZ mice, focusing the attention on the distribution of AAT globules in normal liver, regenerative foci and neoplastic nodules. METHODS: Liver of 79 PiZ mice and 18 wild type (Wt) was histologically analysed for steatosis, clear cell foci, hyperplasia and neoplasia. The expression of human-AAT transgene and murine AAT, in non-neoplastic liver and in hyperplastic/neoplastic nodules was tested by qPCR and qRT-PCR. RT-PCR was used to study expression of hepatic markers: albumin, alpha-foetoprotein, transthyretin, AAT, glucose-6-phospate, tyrosine aminotransferase. RESULTS: Liver pathology was seen more frequently in PiZ (47/79) than in Wt (5/18) and its development was age related. In older PiZ mice (18-24 m), livers showed malignant tumours (HCC and angiosarcoma) (17/50), hyperplastic nodules (28/50), non-specific changes (33/50), whereas only 9/50 were normal. Both human-AATZ DNA and mRNA showed no differences between tumours/nodules and normal liver, while murine-AAT mRNA was reduced in tumours/nodules. CONCLUSION: Accumulation of AAT is associated with an increased risk of liver nodules. The presence of globule-devoid hepatocytes and the reduced expression of murine-AAT mRNA in hyperplastic and neoplastic nodules suggest that these hepatic lesions in AATD could originate from proliferating dedifferentiated cells, lacking AAT storage and becoming capable of AFP re-expression. CI - (c) 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Giovannoni, Isabella AU - Giovannoni I AD - Department of Pathology, Children's Hospital Bambino Gesu, IRCCS, Rome, Italy. FAU - Callea, Francesco AU - Callea F FAU - Stefanelli, Marta AU - Stefanelli M FAU - Mariani, Riccardo AU - Mariani R FAU - Santorelli, Filippo M AU - Santorelli FM FAU - Francalanci, Paola AU - Francalanci P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140311 PL - United States TA - Liver Int JT - Liver international : official journal of the International Association for the Study of the Liver JID - 101160857 RN - 0 (Biomarkers) RN - 0 (DNA Primers) RN - 0 (Prealbumin) RN - 0 (Serum Albumin) RN - 0 (alpha 1-Antitrypsin) RN - 0 (alpha-Fetoproteins) RN - 56-73-5 (Glucose-6-Phosphate) RN - EC 2.6.1.5 (Tyrosine Transaminase) RN - alpha-1-Antitrypsin Deficiency, Autosomal Recessive SB - IM MH - Animals MH - Biomarkers/*blood MH - DNA Primers/genetics MH - *Disease Models, Animal MH - Glucose-6-Phosphate/blood MH - Histological Techniques MH - Immunohistochemistry MH - Liver/*pathology MH - Mice MH - Prealbumin/metabolism MH - Real-Time Polymerase Chain Reaction MH - Serum Albumin MH - Statistics, Nonparametric MH - Tyrosine Transaminase/blood MH - alpha 1-Antitrypsin/blood MH - alpha 1-Antitrypsin Deficiency/*pathology MH - alpha-Fetoproteins/metabolism OTO - NOTNLM OT - AAT globules hepatocellular carcinoma OT - alpha-1-antitrypsin deficiency OT - dedifferentiated cells OT - transgenic mouse EDAT- 2014/02/18 06:00 MHDA- 2015/09/29 06:00 CRDT- 2014/02/18 06:00 PHST- 2013/10/28 00:00 [received] PHST- 2014/02/08 00:00 [accepted] PHST- 2014/02/18 06:00 [entrez] PHST- 2014/02/18 06:00 [pubmed] PHST- 2015/09/29 06:00 [medline] AID - 10.1111/liv.12504 [doi] PST - ppublish SO - Liver Int. 2015 Jan;35(1):198-206. doi: 10.1111/liv.12504. Epub 2014 Mar 11.